News
- Author:
- Brenda Goodman, MA
Publish date: December 23, 2021
“This is helping us quantify how much less severe Omicron is than Delta.”
News
- Author:
- Brenda Goodman, MA
Publish date: December 20, 2021
Pfizer reported that its 3-microgram dose generated a protective immune response in those aged 6-24 months but didn’t generate adequate immunity fo...
News
- Author:
- Brenda Goodman, MA
Publish date: December 16, 2021
The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.
News
- Author:
- Brenda Goodman, MA
Publish date: December 9, 2021
Early studies suggest that booster doses may be necessary to keep Omicron at bay, at least until new variant-specific vaccines are ready next sprin...
News
- Author:
- Brenda Goodman, MA
Publish date: December 9, 2021
“The strains so far vary by their degree of being neutralized by the antibodies from these vaccines, but they are being neutralized nonetheless.”
News
- Author:
- Brenda Goodman, MA
Publish date: December 2, 2021
“This news is concerning, but it is not a surprise.”
News
- Author:
- Brenda Goodman, MA
Publish date: December 2, 2021
The measures are part of a suite of new actions President Joe Biden is expected to announce later today, Dec. 2, in the wake of the arrival of the ...
News
- Author:
- Brenda Goodman, MA
Publish date: November 30, 2021
If authorized by the agency, molnupiravir would be first antiviral agent available as a pill to treat COVID-19.
News
- Author:
- Brenda Goodman, MA
Publish date: November 30, 2021
The new results seem to put molnupiravir far below the effectiveness of existing treatments.
News
- Author:
- Brenda Goodman, MA
Publish date: November 19, 2021
More than 70 million adults are now eligible for booster shots in the United States, but only about 31 million people have received one.
News
- Author:
- Brenda Goodman, MA
Publish date: November 19, 2021
The CDC’s Advisory Committee on Immunization Practices will meet on Nov. 19 to review the science supporting a more widespread need for booster dos...
News
- Author:
- Brenda Goodman, MA
Publish date: November 10, 2021
Memory B cells generated by infections may be immunological Swiss Army Knives, but maybe we really only need a single blade.
News
- Author:
- Brenda Goodman, MA
Publish date: November 5, 2021
The medication appears to work so well that Pfizer has stopped enrollment in the trial of the drug, which works by blocking a protease that the new...
News
- Author:
- Brenda Goodman, MA
Publish date: October 29, 2021
As soon as the CDC’s director signs off on those recommendations, children can get the shots, perhaps as early as Nov. 3.
News
- Author:
- Brenda Goodman, MA
Publish date: October 26, 2021
If the FDA follows the recommendation, as it typically does, ...the shots could be available within days.
